Bone health in cancer patients: ESMO Clinical Practice Guidelines

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Chris Parker, Sten Nilsson, Daniel Heinrich et al. · New England Journal of Medicine · 2013 · 3.3K citations

Medicine, Nuclear Medicine, Radiation Oncology +17

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Dennis M. Black, Pierre D. Delmas, Richard Eastell et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

FRAX™ and the assessment of fracture probability in men and women from the UK

John А. Kanis, Olof Johnell, Håkan Johansson et al. · Osteoporosis International · 2008 · 2.4K citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Karim Fizazi, Michael A. Carducci, Matthew R. Smith et al. · The Lancet · 2011 · 2K citations · Full text

Medicine, Oncology, Urology +17

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Alison Stopeck, Allan Lipton, Jean-Jacques Body et al. · Journal of Clinical Oncology · 2010 · 1.6K citations

Medicine, Pharmacology, Pharmacotherapy +17